Synthesis and in vivo evaluation of p-18F-fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET

Journal of Nuclear Medicine

Volumn 52, Issue 1, 2011, Pages 147-153

  Awasthi, Vibhudutta ^a   Pathuri, Gopal ^a   Agashe, Hrushikesh B ^a   Gali, Hariprasad ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

ERPF; PET; Radiopharmaceuticals; Renal; Renal function; Renogram

Indexed keywords

DRUG METABOLITE; FLUORINE 18 FLUOROHIPPURATE; PROBENECID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; NONHUMAN; PLASMA; PLASMA CLEARANCE; PLASMA PROTEIN BINDING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RENOGRAPHY; URINALYSIS;

ANIMALS; DRUG STABILITY; FEMALE; FLUORINE RADIOISOTOPES; HIPPURATES; HUMANS; ISOTOPE LABELING; KIDNEY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79851477826     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.075895     Document Type: Article

References (34)

1. Killion D, Nitzsche E, Choi Y, Schelbert H, Rosenthal JT. Positron emission tomography: a new method for determination of renal function. J Urol. 1993;150:1064-1068. (Pubitemid 23241336)
2. Shelton M, Green M, Mathias C, Welch M, Bergmann S. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation. 1990;82:990-997. (Pubitemid 20316751)
3. Green MA, Mathias CJ, Willis LR, et al. Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion. Nucl Med Biol. 2007;34:247-255. (Pubitemid 46441858)
4. Yamashita M, Inaba T, Kawase Y, et al. Quantitative measurement of renal function using Ga-68-EDTA. Tohoku J Exp Med. 1988;155:207-208.
5. Goethals P, Volkaert A, Vandewielle C, Dierckx R, Lameire N. 55Co-EDTA for renal imaging using positron emission tomography (PET): a feasibility study. Nucl Med Biol. 2000;27:77-81. (Pubitemid 30099618)
6. 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging. 2008;35:2267-2274.
7. Szabo Z, Xia J, Mathews WB, Brown PR. Future direction of renal positron emission tomography. Semin Nucl Med. 2006;36:36-50. (Pubitemid 41779366)
8. 99mTc-DTPA (stannous). AJR. 1982;138:565-570.
9. 99mTc-DTPA for measurement of glomerular filtration rate. J Nucl Med. 1976;17:317-320.
10. 99mTc-MAG3 renography: normal values for mag3 clearance and curve parameters, excretory parameters, and residual urine volume. AJR. 2006;187:W610-W617.
11. Itoh K. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function. Ann Nucl Med. 2001;15:179-190. (Pubitemid 32679209)
12. Taylor A Jr, Eshima D, Fritzberg AR, Christian PE, Kasina S. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. J Nucl Med. 1986;27:795-803. (Pubitemid 17022667)
13. Jamar F, Barone R. Renal imaging. In: Baert A, Sartor K, Schiepers C, eds. Diagnostic Nuclear Medicine. Heidelberg, Germany: Springer; 2006:83-100.
14. Pathuri G, Agashe HB, Awasthi V, Gali H. Radiosynthesis and in vivo evaluation of a F-18-labeled pancreatic islet amyloid inhibitor. J Labelled Comp Radiopharm. 2010;53:186-191.
15. Hutt AJ, Caldwell J. Amino acid conjugation. In: Mulder GJ, ed. Conjugation Reactions in Drug Metabolism. London, U.K.: Taylor and Francis Ltd.; 1990:273-305.
16. Tremblay GC, Qureshi IA. The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen. Pharmacol Ther. 1993;60:63-90. (Pubitemid 24052882)
17. 18F]fluorocarboxylic acids. Appl Radiat Isot. 1994;45:715-727.
18. 18F. Nat Protoc. 2006;1:1655-1661.
19. 18F]SFB) for protein labeling. J Labelled Comp Radiopharm. 2008;51:68-71.
20. Eshima D, Taylor A Jr, Fritzberg AR, Kasina S, Hansen L, Sorenson JF. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents. J Nucl Med. 1987;28:1180-1186. (Pubitemid 17146836)
21. 131I-OIH. J Nucl Med. 2009;50:454-460.
22. Blaufox MD, Guttmann RD, Merrill JP. Measurement of renal function in the rat with single injection clearances. Am J Physiol. 1967;212:629-632.
23. Sapirstein LA, Vidt DG, Mandel MJ, Hanusek G. Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol. 1955;181:330-336.
24. HE W, Fischman AJ. Nuclear imaging in the genitourinary tract: recent advances and future directions. Radiol Clin North Am. 2008;46:25-43. (Pubitemid 351323819)
25. Russell CD, Dubovsky EV. Measurement of renal function with radionuclides. J Nucl Med. 1989;30:2053-2057. (Pubitemid 20024329)
26. Blaufox MD. Procedures of choice in renal nuclear medicine. J Nucl Med. 1991;32:1301-1309.
27. 131I-OIH in healthy volunteers. J Nucl Med. 2010;51:391-396.
28. 99mTc-EC. J Nucl Med. 2004;45:885-891.
29. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a Hippuran replacement. J Nucl Med. 1986;27:111-116. (Pubitemid 17023179)
30. 99mTc-MAG3 via rat renal organic anion transporter 1. J Nucl Med. 2004;45:80-85.
31. Despopoulos A. A definition of substrate specificity in renal transport of organic anions. J Theor Biol. 1965;8:163-192.
32. Coveney JR, Robbins MS. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in Rats. J Nucl Med. 1987;28:1881-1887. (Pubitemid 18017099)
33. Jafri RA, Britton KE, Nimmon CC, et al. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J Nucl Med. 1988;29:147-158. (Pubitemid 18056724)
34. Chauser BM, Hudson FR, Law MP. Renal function in the rat following irradiation. Radiat Res. 1976;67:86-97.